摘要
背景:增生性玻璃体视网膜病变(PVR)是一个由分化的疾病,与多种细胞增殖迁移的地方。这些细胞形成纤维细胞膜导致视网膜脱离,视力丧失。PVR发生在原发性视网膜脱离(RD)患者中的8% - 10%,成为RD修复成功的主要障碍。视网膜色素上皮(RPE)细胞是主要的细胞组成的纤维细胞膜间。reproliferation和上皮间质转化(EMT)是PVR视网膜色素上皮细胞的主要病理改变。 方法:用不同浓度姜黄素处理RPE细胞24, 48、72小时。MTT法检测活细胞。RPE细胞的凋亡multicaspase V/7-AAD染色和流式细胞仪检测。PI染色定量分析细胞周期。实时荧光定量PCR检测mrna水平。蛋白印迹法检测蛋白水平。 结果:姜黄素对体外培养的RPE细胞增殖和EMT有明显的抑制作用。进一步研究表明姜黄素通过p53途径激活G2检查点诱导细胞周期阻滞。同时,我们发现姜黄素抑制RPE细胞中的Akt、MAPK和TGF-β通路,也可能影响增殖和EMT。我们的研究发现姜黄素是一种潜在的预防和治疗PVR的新药物。姜黄素激活G2检查点诱导细胞周期阻滞。 结论:本研究结果也为拓宽姜黄素在临床研究中的应用提供了思路。
关键词: 姜黄素,增生性玻璃体视网膜病变,视网膜色素上皮细胞、纤维细胞的细胞膜、细胞周期。
Current Molecular Medicine
Title:Curcumin Inhibits Proliferation and Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells Via Multiple Pathways
Volume: 17 Issue: 4
关键词: 姜黄素,增生性玻璃体视网膜病变,视网膜色素上皮细胞、纤维细胞的细胞膜、细胞周期。
摘要: Background: Proliferative vitreoretinopathy (PVR) is a disease caused by dedifferentiation, translocation and proliferation of several types of local cells. These cells form fibrocellular membranes resulting in detachment of retinal and vision loss. PVR occurs in 8%-10% of patients undergoing primary retinal detachment (RD) surgery and becomes a major obstacle for successful RD repair. Retinal pigment epithelial (RPE) cells are among the major cells which consist of fibrocellular membranes. Reproliferation and Epithelial-mesenchymal transition (EMT) are the primary pathological alteration of RPE cells in PVR.
Methods: RPE cells were treated with curcumin at different concentrations for 24, 48 and 72 hours. The viable cells were detected by MTT assay. The apoptosis of RPE was stained by Multicaspase/7-AAD and detected using flow cytometry. Cell cycle analysis was quantified by PI staining. The mRNA levels were detected by real-time PCR. The protein levels were detected by western blot.
Results: We found a compound curcumin significantly inhibited proliferation and EMT of RPE cells in vitro. Further study showed curcumin induced cell cycle arrest by activating G2 checkpoint through p53 pathway. Meanwhile, we found that curcumin suppressed the AKT, MAPK and TGF-β pathways in RPE cells which may also affect proliferation and EMT. Our research identified curcumin a potential novel agent for the PVR prevention and treatment. Curcumin induces cell cycle arrest by activating G2 checkpoint.
Conclusion: Our results in this study also provide the insights to broaden the application of curcumin in research and probably clinics.
Export Options
About this article
Cite this article as:
Curcumin Inhibits Proliferation and Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells Via Multiple Pathways, Current Molecular Medicine 2017; 17 (4) . https://dx.doi.org/10.2174/1566524017666171106115655
DOI https://dx.doi.org/10.2174/1566524017666171106115655 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Maintenance Therapy in Multiple Myeloma: Novel Concepts in Clinical Practice from Recent Clinical Trials
Reviews on Recent Clinical Trials Mining the Adenovirus "Virome" for Systemic Oncolytics
Current Pharmaceutical Biotechnology Towards Improved Therapies Using Nanopharmaceuticals: Recent Patents on Pharmaceutical Nanoformulations
Recent Patents on Food, Nutrition & Agriculture Proteasome Inhibition in Transplantation-Focusing on the Experience with Bortezomib
Current Pharmaceutical Design New Treatment Concepts In Diffuse Large B-Cell Lymphomas (DLBL): Chemotherapy and Biological Therapy
Reviews on Recent Clinical Trials Understanding and Targeting Osteoclastic Activity in Prostate Cancer Bone Metastases
Current Molecular Medicine Unfolding the Pathophysiological Role of Bioactive Lysophospholipids
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Pyruvate Kinase M2: Regulatory Circuits and Potential for Therapeutic Intervention
Current Pharmaceutical Design Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
Current Medicinal Chemistry Interleukin-21 in Immune and Allergic Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Mechanism of Anti-Tumor Effect by Curcumin in Hematological Malignancies
Current Pharmaceutical Analysis How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization
Mini-Reviews in Medicinal Chemistry A Review on Hematopoietic Stem Cell Treatment for Epilepsy
CNS & Neurological Disorders - Drug Targets A High-Throughput Screening Assay for Determining Cellular Levels of Total Tau Protein
Current Alzheimer Research Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy
Current Topics in Medicinal Chemistry Targeting P-glycoprotein for Effective Oral Anti-Cancer Chemotherapeutics
Current Cancer Drug Targets Gene Therapy for Immunologic Tolerance: Using Bone Marrow-Derived Cells to Treat Autoimmunity and Hemophilia
Current Stem Cell Research & Therapy Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment
Current Drug Metabolism Therapeutic Proteins in Tumors and Targeted Therapeutic Agents for Cancer Patients
Protein & Peptide Letters Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System
Current Cancer Drug Targets